Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)
Author:
Publisher
Elsevier BV
Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference104 articles.
1. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy;Camargo;Transpl Infect Dis,2021
2. Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients;Mushtaq;Transplant Cell Ther,2021
3. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey;Ljungman;Leukemia,2021
4. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study;Sharma;Lancet Haematol,2021
5. Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients;Waghmare;Biol Blood Marrow Transplant,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes;Frontiers in Cellular and Infection Microbiology;2023-10-19
2. Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study;Bone Marrow Transplantation;2023-10-06
3. COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy;Transplant Infectious Disease;2023-09-28
4. Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit;Expert Review of Anticancer Therapy;2023-09-02
5. Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances;Transplant Infectious Disease;2023-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3